Desktop Site
|
18 Oct 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
81,224.75
+218.14
+0.27 %
Corporate Announcement
Security Code
532321
Company
Zydus Lifesciences Ltd
Exchange Received Time
14/10/2024 16:18:08
Exchange Disseminated Time
14/10/2024 16:18:08
Time Taken
00:00:00
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
10/14/2024 4:18:08 PM
Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease.
Attachment
<< Back
Recently Viewed